You searched for prescription-drugs | Page 43 of 179

Prices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020

Feb 25, 2022

Issue Brief

Recent legislation would require drug companies to pay rebates to the federal government when annual increases in prescription drug prices for Medicare and private insurance exceed the rate of inflation. As context for understanding the possible impact of this proposal, this analysis compares price changes for drugs covered by Medicare Part B (administered by physicians) and Part D (retail prescription drugs) between 2019 and 2020 to the inflation rate over the same period.

Medicaid Coverage of Behavioral Health Services in 2022: Findings from a Survey of State Medicaid Programs

Mar 17, 2023

Issue Brief

To better understand the variation in access to behavioral health services for adults in Medicaid, KFF surveyed state Medicaid officials about behavioral health benefits covered for adult enrollees in their fee-for-service programs.

KFF Health Tracking Poll – March 2022: Economic Concerns and Health Policy, The ACA, and Views of Long-term Care Facilities

Mar 31, 2022

Feature

This poll finds the public's health care priorities for Congress focus on reducing out-of-pocket costs, and concerns over inflation and the economy are top of mind as voters begin to think about the November midterm elections. The poll also examines views of the ACA and nursing homes.

Strategies to Manage Unwinding Uncertainty for Medicaid Managed Care Plans: Medical Loss Ratios, Risk Corridors, and Rate Amendments

Apr 10, 2023

Issue Brief

This brief provides a high-level snapshot of states with minimum medical loss ratio (MLR) and remittance requirements and risk corridors in place as of July 1, 2022 that may provide financial protection and limits on financial risk for states and plans as the unwinding unfolds.

KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year

Sep 14, 2023

News Release

As Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it. Based on interviews with nearly 80 representatives from private insurance plans, state Medicaid programs, chain pharmacies, and other key groups, the report provides a deeper view into the operational challenges in expanding access to…

Fate of Medicaid Expansion and Filling the Coverage Gap May Once Again Depend on the Outcome of State Elections

Aug 17, 2022

Policy Watch

This post examines the potential for this year's midterm elections to decide the fate of Medicaid expansion, with gubernatorial races in 10 of the 12 states that have not expanded, including Georgia, Kansas and Wisconsin, where the gubernatorial race is considered a toss-up. South Dakota voters also will decide a Medicaid expansion ballot initiative.

Medicare Part B Drugs: Cost Implications for Beneficiaries in Traditional Medicare and Medicare Advantage

Mar 15, 2022

Issue Brief

In the face of rising prescription drug costs, a large majority of the public supports federal efforts to lower drug spending. Policymakers are considering several proposals that would lower prescription drug costs. To better understand the potential out-of-pocket cost exposure that Medicare beneficiaries may face for Part B drugs, which are typically administered by physicians and other health care providers, we analyzed cost-sharing liability for these drugs in traditional Medicare and cost-sharing requirements in Medicare…

CMS Prior Authorization Proposal Aims to Streamline the Process and Improve Transparency

Feb 21, 2023

Issue Brief

This brief explains a new proposed federal regulation aimed at reducing administrative hassles involved in obtaining prior authorization for care and sets out key policy questions, including how the proposal could impact the patient experience and data privacy.

KFF Health Tracking Poll May 2023: Health Care in the 2024 Election and in the Courts

May 26, 2023

Feature

Nearly a year after the Supreme Court overturned Roe v. Wade, this poll examines the public's views of abortion and the Supreme Court, and knowledge about mifepristone, a medication abortion drug that is the subject of another court case, the ACA's preventive services provision and HIV in the US.

Recent Developments and Key Issues to Watch with Medicaid Section 1115 Waivers

Sep 28, 2022

Policy Watch

This policy watch describes the current landscape of Section 1115 waivers and highlights key issues to watch: the outcome of litigation related to Georgia’s waiver, as well as the Biden Administration’s decisions on pending requests from Tennessee and other states.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter